ConductScience.org, home

Paper39102176

Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations.

Rippin G and 10 others. Drug Saf, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations. Papers, record 39102176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39102176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations.
PubMed
Journal
Drug Saf
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.57, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rippin GGerdhttps://orcid.org/0000-0001-6293-8465
2Sanz HHéctor
3Hoogendoorn WEWilhelmina E
4Ballarini NMNicolás M
5Largent JAJoan A
6Demas EEleni
7Postmus DDouwe
8Framke TTheodor
9Dávila LMALukas M Aguirre
10Quinten CChantal
11Pignatti FFrancesco

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Multiple MyelomaMajor topic
Randomized Controlled Trials as TopicMajor topic
Computer SimulationMajor topic
BiasMajor topic
Humans
Male
Confounding Factors, Epidemiologic
Research Design
Sample Size
Data Interpretation, Statistical

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
EMA/2017/09/PEEuropean Medicines AgencyPubMed
Lot 4European Medicines AgencyPubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132440224Synthetic and External Controls in Clinical Trials - A Primer for Researchers.Clin Epidemiol2020https://conductscience.org/library/papers/32440224PubMed
231335166An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer.JCO Clin Cancer Inform2019https://conductscience.org/library/papers/31335166PubMed
330878639The proportion of missing data should not be used to guide decisions on multiple imputation.J Clin Epidemiol2019https://conductscience.org/library/papers/30878639PubMed
429207961When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.BMC Med Res Methodol2017https://conductscience.org/library/papers/29207961PubMed
530636285Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making.Clin Pharmacol Ther2019https://conductscience.org/library/papers/30636285PubMed
634014439The Use of External Controls in FDA Regulatory Decision Making.Ther Innov Regul Sci2021https://conductscience.org/library/papers/34014439PubMed
730987939
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.
Lancet Oncol2019https://conductscience.org/library/papers/30987939PubMed
832440847A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data.Drug Saf2020https://conductscience.org/library/papers/32440847PubMed
935895225A Review of Causal Inference for External Comparator Arm Studies.Drug Saf2022https://conductscience.org/library/papers/35895225PubMed
1031350853Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.Clin Pharmacol Ther2020https://conductscience.org/library/papers/31350853PubMed
1129059439Real-world Data for Clinical Evidence Generation in Oncology.J Natl Cancer Inst2017https://conductscience.org/library/papers/29059439PubMed
1240980106External Comparator Cohort studies - clarification of terminology.Front Drug Saf Regul2023https://conductscience.org/library/papers/40980106PubMed
1333908160The use of external controls: To what extent can it currently be recommended?Pharm Stat2021https://conductscience.org/library/papers/33908160PubMed
1437097356Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.JAMA2023https://conductscience.org/library/papers/37097356PubMed
1530257058Closed-form variance estimator for weighted propensity score estimators with survival outcome.Biom J2018https://conductscience.org/library/papers/30257058PubMed
1631541454Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.Clin Pharmacol Ther2020https://conductscience.org/library/papers/31541454PubMed
1730819708Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review.BMJ Open2019https://conductscience.org/library/papers/30819708PubMed
1831063192Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples.Am J Epidemiol2019https://conductscience.org/library/papers/31063192PubMed
1929944008Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib.J Comp Eff Res2018https://conductscience.org/library/papers/29944008PubMed
2030031168The use of real-world data in cancer drug development.Eur J Cancer2018https://conductscience.org/library/papers/30031168PubMed

See all 37 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41669939Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.Clin Pharmacol Ther2026https://conductscience.org/library/papers/41669939PubMed
41021206Choosing an Index Date for Untreated Patients in External Comparator Studies.Drug Saf2026https://conductscience.org/library/papers/41021206PubMed
40979390External comparator studies and the joint application of the estimand and target trial emulation frameworks.Front Drug Saf Regul2024https://conductscience.org/library/papers/40979390PubMed
40835783External Comparator Studies: Performance of Four Missing Data-Handling Approaches, Stratified by Four Different Marginal Estimators.Drug Saf2025https://conductscience.org/library/papers/40835783PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39102176

GET https://conductscience.org/api/papers/v1/39102176/references?page=2